1. |
FOSTER C R, ZHA Q, DANIEL L L, et al. Lack of ataxia telangiectasia mutated kinase induces structural and functional changes in the heart:role inβ-adrenergic receptor-stimulated apoptosis[J]. Exp Physiol, 2012, 97(4):506-515.
|
2. |
GORR M W, STEVENS S C, WOLD L E. Ataxia telangiectasia mutated kinase in the heart:currency for myocyte apoptosis[J]. Exp Physiol, 2012, 97(4):476.
|
3. |
BHATTI S, KOZLOV S, FAROOQI A A, et al. ATM protein kinase:the linchpin of cellular defenses to stress[J]. Cell Mol Life Sci, 2011, 68(18):2977-3006.
|
4. |
SHEN L, YIN Z H, WAN Y, et al. Association between ATM polymorphisms and cancer risk:a meta-analysis[J]. Mol Biol Rep, 2012, 39(5):5719-5725.
|
5. |
SOUKUPOVA J, POHLREICH P, SEEMANOVA E. Characterisation of ATM mutations in Slavic Ataxia telangiectasia patients[J]. Neuromolecular Med, 2011, 13(3):204-211.
|
6. |
FOSTER C R, SINGH M, SUBRAMANIAN V, et al. Ataxia telangiectasia mutated kinase plays a protective role inβ-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling[J]. Mol Cell Biochem, 2011, 353(1-2):13-22.
|
7. |
CHEN T, DONG B, LU Z, et al. A functional single nucleotide polymorphism in promoter of ATM is associated with longevity[J]. Mech Ageing Dev, 2010, 131(10):636-640.
|
8. |
PARK J, JO Y H, CHO C H, et al. ATM-deficient human fibroblast cells are resistant to low levels of DNA double-strand break induced apoptosis and subsequently undergo drug-induced premature senescence[J]. Biochem Biophys Res Commun, 2013, 430(1):429-435.
|
9. |
WANG Y J, SUN H, LIU G T, et al. Advances in the study of p53 in response to DNA damage[J]. Yao Xue Xue Bao, 2011, 46(12):1413-1419.
|
10. |
刘璐, 廖绍光, 王宁, 等.ATM在淋巴结阴性乳腺癌中的表达及临床意义[J].医学研究杂志, 2012, 41(9):40-43.
|
11. |
JU Z, ZHANG J, GAO Y, et al. Telomere dysfunction and cell cycle checkpoints in hematopoietic stem cell aging[J]. Int J Hematol, 2011, 94(1):33-43.
|
12. |
COSENTINO C, GRIECO D, COSTANZO V. ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair[J]. EMBO J, 2011, 30(3):546-555.
|
13. |
柴笑, 赵明峰.活性氧与骨髓造血干细胞衰老研究进展[J].中国实验血液学杂志, 2012, 20(6):1518-1521.
|
14. |
KASSI E, PERVANIDOU P, KALTSAS G, et al. Metabolic syndrome:definitions and controversies[J]. BMC Med, 2011, 9(48):48.
|
15. |
ZHOU K, BELLENGUEZ C, SPENCER C C, et al. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes[J]. Nat Genet, 2011, 43(2):117-120.
|
16. |
沈燕, 黎红华.胰岛素抵抗导致动脉粥样硬化的机制研究[J].神经损伤与功能重建, 2012, 7(5):377-379.
|
17. |
LI S, ZHANG L, CHEN T, et al. Functional polymorphism rs189037 in the promoter region of ATM gene is associated with angiographically characterized coronary stenosis[J]. Atherosclerosis, 2011, 219(2):694-697.
|
18. |
MERCER J R, YU E, FIGG N, et al. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/-mice[J]. Free Radic Biol Med, 2012, 52(5):841-849.
|
19. |
PATEL A Y, MCDONALD T M, SPEARS L D, et al. Ataxia telangiectasia mutated influences cytochrome c oxidase activity[J]. Biochem Biophys Res Commun, 2011, 405(4):599-603.
|
20. |
WEIZMAN N, SHILOH Y, BARZILAI A. Contribution of the ATM protein to maintaining cellular homeostasis evidenced by continuous activation of the AP-1 pathway in ATM-deficient brains[J]. J Biol Chem, 2003, 278(9):6741-6747.
|
21. |
张薇.胰岛素抵抗在氧化应激致动脉粥样硬化中的作用[J].内蒙古医学杂志, 2013, 45(2):184-187, 138.
|
22. |
SCHNEIDER J G, FINCK B N, REN J, et al. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome[J]. Cell Metab, 2006, 4(5):377-389.
|
23. |
YU E, CALVERT P A, MERCER J R, et al. Mitochondrial DNA damage can promote atherosclerosis independently of reactive Oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans[J]. Circulation, 2013, 128(7):702-712.
|
24. |
ARMATA H L, GOLEBIOWSKI D, JUNG D Y, et al. Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis[J]. Mol Cell Biol, 2010, 30(24):5787-5794.
|
25. |
FENG Z, HU W, TERESKY A K, et al. Declining p53 function in the aging process:a possible mechanism for the increased tumor incidence in older populations[J]. Proc Natl Acad Sci U S A, 2007, 104(42):16633-16638.
|
26. |
CHEN M Z, CHENG G H, MA L, et al. Association study between TNFSF4 and coronary heart disease[J]. Hereditas, 2011, 33(3):239-245.
|
27. |
SMIRNOV D A, CHEUNG V G. ATM gene mutations result in both recessive and dominant expression phenotypes of genes and microRNAs[J]. Am J Hum Genet, 2008, 83(2):243-253.
|
28. |
ZHOU Y, WAN G, SPIZZO R, et al. miR-203 induces oxaliplatin resistance in colorectal Cancer cells by negatively regulating ATM kinase[J]. Mol Oncol, 2014, 8(1):83-92.
|
29. |
LU P H, WEI M X, SI S P, et al. Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk:evidence from the current studies[J]. Breast Cancer Res Treat, 2011, 126(1):141-148.
|
30. |
KIM J W, IM S A, KIM M A, et al. Ataxia-telangiectasia mutated protein expression with microsatellite instability in gastric cancer as prognostic marker[J]. Int J Cancer, 2014, 134(1):72-80.
|